logo
Shashi Tharoor offers an explanation on Trump's ‘dead economy' remark

Shashi Tharoor offers an explanation on Trump's ‘dead economy' remark

Congress MP Shashi Tharoor has said that former US President Donald Trump's description of India as a 'dead economy' was intended as an 'insult' and should not be interpreted 'literally'. Congress MP Shashi Tharoor at Parliament premises during the ongoing monsoon session, in New Delhi.(ANI)
Speaking in Pune on Sunday during a conversation with Crossword CEO Aakash Gupta, Tharoor said India must remain clear-eyed about its national interests, especially at a time when global powers are contributing to instability rather than order.
The senior Congress leader addressed a range of subjects during the discussion, including his latest book, The Living Constitution.
Trump had last week referred to India as a 'dead economy', hours after announcing a 25 per cent tariff on Indian imports and hinting at additional penalties for India's continued purchase of Russian crude oil and military equipment.
Tharoor said such comments come amid an increasingly volatile and unpredictable global landscape, especially with Trump in a position of power.
"On Trump, let me say, you can't take him literally, but you do need to take him seriously. He is the President of the US, and the decisions he makes can affect policies, and policies can affect us. So take him seriously, but don't take him literally, not every word. When he says your economy is dead, it's like a schoolboy in the playground saying your mother is ugly. You are not supposed to take that seriously. It is meant to be an insult, not meant to be taken literally," he said.
Tharoor noted that the global impact of Trump's tariff policies over the past six months has been significant, and India, too, has felt the effects in recent days.
"We are going to have to recover because the American relationship, and I don't just mean the trade relationship, the strategic partnership, is important enough for us to want to make the real effort to make this work. So I think there is a lot that needs to be done," he said.
He also questioned the credibility of international institutions like the UN and its Security Council, given the active role major powers are playing in ongoing conflicts.
"...the wars are being conducted with the active involvement of some of the biggest powers in the world. And that, again, means that the people who are supposed to be upholding world order are contributing to promoting disorder. In the midst of all this, what does India do to navigate its position? Well, first of all, of course, we have to be very clear in our minds what our national interests are," Tharoor said.
He stressed that India's top priority should be the well-being of its people.
"And that means focusing on our development, on our prosperity, on our harmony, on our coexistence with each other, and on the safety and security of our borders as well, which have recently been threatened both from the Chinese side and the Pakistani side. And we have to be prepared to be robustly able to defend ourselves without jeopardising the larger story of our development and our growth," he said.
On the global stage, Tharoor said India must assert itself as a key player.
"We have to be amongst the rule makers and not just the rule takers. We have to be a significant player so that we are not in a position where others can dictate to us or push us around. Our credibility matters. We are already the most populous country in the world. We are already amongst the largest economies in the world and will soon be the third largest. In all these circumstances, we do matter. We have to be counted. But at the same time, we have to be sure what we want to be counted for," he asserted.
He expressed confidence that India, with a clear understanding of its priorities and interests, will be able to navigate today's uncertainty with competence.
Asked about the delegation he led to the United States to explain Operation Sindoor and his meeting with US Vice President JD Vance, Tharoor said, "We had extremely good and effective meetings as not only was our message well received, but it was almost repeated back to us with sympathy, understanding, and respect."
"I had a very limited mandate. We were just there to explain Operation Sindoor, why we did what we did, what the thing was all about and what it was not all about, and the fact that we had to convey to the outside world that if terrorists strike us again, we will have to strike back again, so they better be prepared for that. And those messages were very clearly respected, understood, and applauded," he added.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Eris Lifesciences eyes ‘good' share in semaglutide generics, says COO
Eris Lifesciences eyes ‘good' share in semaglutide generics, says COO

Economic Times

time18 minutes ago

  • Economic Times

Eris Lifesciences eyes ‘good' share in semaglutide generics, says COO

Mr. Krishnakumar Vaidyanathan, Executive Director & Chief Operating Officer Eris Lifesciences looks to leverage its experience in integrated diabetes portfolio to take a lead among the first wave of generic semaglutide anti-diabetic and weight-loss drugs to hit the market early next year, a top official said. The company is looking at a 'good' share of the market, Krishnakumar Vaidyanathan, executive director and chief operating officer of Eris Lifesciences, told ET in an interaction. Semaglutide is the active ingredient in Novo Nordisk's blockbuster drugs Wegovy and Ozempic. Its patent in India will expire in March 2026. 'We are gearing up to be among the first to enter the market post loss of exclusivity,' Vaidyanathan said. 'We expect the overall market for GLP-1 at the end of the first 12 months (after the loss of exclusivity) to be at least 10 million units… And we expect to get a good share of the market.' Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Eris Lifesciences' existing diabetes portfolio includes orals, insulin and GLP-1 in the form of liraglutide. Its network of field representatives, patient connect and service platform in this space gives the firm an advantage over others, Vaidyanathan said. 'We do this day in and day out because of insulin. That gives us the confidence that we'll be able to step this up for GLP-1 as well.'Globally, the GLP-1 market is dominated by Eli Lilly and Novo Nordisk, which are also the two biggest insulin companies in the world. 'Being successful and big in the insulin market provides a huge tailwind when it comes to selling GLPs,' Vaidyanathan said. 'We have combined service with technology and product to create a winning combination in insulin and GLP therapy entry is not any different, which also requires a lot of patient education over and above the service on using the pens,' he said. 'We have an integrated diabetes portfolio because we currently sell GLP-1 in the form of liraglutide.' Dr Reddy's Labs, Sun Pharmaceutical Industries, Cipla, Mankind Pharma, Torrent Pharmaceuticals, and Zydus Lifesciences are also among Indian drugmakers readying to launch generic semaglutide next year. Eris Lifesciences launched liraglutide, a once-a-week GLP-1 product, last September. 'We have taken very good market shares in all the other LOE (loss of exclusivity) opportunities that we have seen in diabetes,' Vaidyanathan said. 'We have taken market ranks of 1 to 5 in each one without exception – vildagliptin, sitagliptin, linagliptin, dapagliflozin and empagliflozin. That gives us the confidence that we should be getting a fair share of the market.' Vishal Manchanda, pharma analyst at brokerage Systematix Group, said its full portfolio of anti-diabetes drugs to offer to diabetologist, spanning all oral and injectable options, should give Eris Lifesciences 'a strong positioning in a market where the large pharma majors like Sun, Lupin, Dr Reddy's, Cipla, Mankind and Zydus come in with their dominant brand presence.'

Vedanta continues winning street confidence: Brokerages forecast strong earnings ahead
Vedanta continues winning street confidence: Brokerages forecast strong earnings ahead

Hans India

time20 minutes ago

  • Hans India

Vedanta continues winning street confidence: Brokerages forecast strong earnings ahead

New Delhi: Major global and Indian brokerages remain optimistic on Vedanta Ltd's performance for FY26, citing stronger LME pricing trends, cost discipline, deleveraging, and a resilient aluminium business among the key growth drivers. These firms have also taken note of the several growth projects scheduled for commissioning or completion in the next few quarters. JP Morgan noted that Vedanta's first quarter consolidated EBITDA was largely in line with estimates, with key segments such as aluminium, oil and gas, and power faring better than its expectations, leading to an overall segmental EBITDA beat. On the earnings trajectory for the current and next fiscal, the firm expects various ongoing initiatives at Vedanta to aid growth. "Vedanta's capacity expansion journey in the aluminium business as well as vertical integration should bring cost advantages. LME prices have also bottomed out and should continue to move higher into FY26-27, likely aiding earnings growth." Echoing similar views on LME prices and its potential benefit, Citi Research cited that Vedanta's parent (Vedanta Resources) leverage is at comfortable levels. It listed potential upside in medium-term aluminium LME prices, lower cost, and the demerger as another positive for Vedanta, while adding that aluminium globally has a limited supply growth. Mumbai-based Nuvama Institutional Equities expects Vedanta to deliver quarter-on-quarter EBITDA growth in Q2. "Q2FY26 EBITDA is likely to increase 10 per cent-plus quarter-on-quarter on the back of higher prices and lower aluminium cost of production. Major aluminium projects are likely to be commissioned in Q2FY26. We reckon net debt/EBITDA ex-Hindustan Zinc shall fall to 1.7x by FY26-end, compared to 2.7x in FY25. Demerger of the business is likely to be concluded in Q4FY26," the firm said in its report. The brokerage expects Vedanta's all major projects except coal blocks to be likely commissioned in the current fiscal, providing volume growth and cost reduction visibility for the company. UK-based Investec stated in its post-earnings report that Vedanta is a key beneficiary of depreciation in the Indian Rupee. Other near-term positives listed by the firm include declining alumina prices and the company offering attractive yields. The firm has retained its buy recommendation on Vedanta. Research firms like Kotak Institutional Equities and IIFL have cited factors like cost efficiencies and deleveraging at both Vedanta Ltd and its parent Vedanta Resources as beneficial factors. Vedanta's adjusted profit after tax jumped 13 per cent year-on-year to Rs 5,000 crore. The company clocked its highest-ever first-quarter EBITDA of Rs 10,746 crore, which was up 5 per cent year-on-year.

SIR in Bihar an 'invasive reconstruction of electoral roll:' Dipankar Bhattacharya
SIR in Bihar an 'invasive reconstruction of electoral roll:' Dipankar Bhattacharya

The Hindu

time20 minutes ago

  • The Hindu

SIR in Bihar an 'invasive reconstruction of electoral roll:' Dipankar Bhattacharya

Describing the Special Intensive Revision (SIR) drive under way in Bihar as 'an invasive reconstruction of the electoral roll,' Dipankar Bhattacharya, general secretary of the Communist Party of India (Marxist-Leninist) Liberation, said States including Kerala should be on guard as it could be applied in other parts of the country as well. 'If they get away with it in Bihar, they will apply it everywhere,' he said, delivering the 24th memorial lecture in memory of the journalist N. Narendran on the topic 'Bihar: Trial run for Mass Disenfranchisement.' 'In fact, some people in Kerala and Tamil Nadu may still be believing that, well, this is something only happening in north India. If it is happening in north India, it is only a matter of time it happens here. No part of India is secure. Every State, every community, every political geography, every social equation, is vulnerable,' he said. The concept of citizenship as Indians have known it no longer remains valid as people will now be forced to prove their citizenship. The migrant workers of Bihar have emerged as one of the most vulnerable sections of electors in the SIR in Bihar, given the Election Commission of India's definition of 'ordinary resident.' This could have implications for Kerala as well, which has a large migrant population, he said. The SIR in Bihar, he said, was not just about rewriting the electoral roll, but it was about rewriting the electoral rules, he said. 'By rewriting the electoral rules, you are rewriting the entire grammar of elections in India,' he said. Mr. Dipankar Bhattacharya said that the INDIA Bloc was the need of the hour, observing that the BJP has grown at the expense of all other parties. 'If we cannot identify who the common enemy is, we will be doing so at our own peril,' he said. He underscored the need for a broad-based, sustained and multi-pronged resistance against what he described as the 'fascist offensive' of the BJP-RSS in the country. On the BJP's 'One Nation, One Election' proposal, Mr. Bhattacharya said it holds grave implications for the concepts of democracy and federalism. 'Every election has its own context. A Lok Sabha election has its own context, an Assembly election has its own context, a panchayat election will have its own context. If you bulldoze, flatten everything into one single narrative, and one single context for the whole elections, there will be nothing left of India's federalism and democracy as we have known it all these years,' he said, adding that the current challenges facing the Indian people is unlike any other in the post-Independence era.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store